However, the expression of PARP3 in patients with pSS was significantly higher than that in normal controls in the training GSE66795 dataset ( P < 0.05), whereas the expression of PARP3 in patients with pSS was lower than that in normal controls in the validation GSE84844 dataset but did not reach statistical significance ( P > 0.05).
← all excerpts
Diagnostic markers and potential therapeutic agents for Sjögren's syndrome screened through multiple machine learning and molecular docking.
1
0.0500
0.0500